USPTO serial 98090425
STRIVE
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- GERMICK JR., EDWARD JOSEPH
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with STRIVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Parsippany, NJ, US
Parsippany, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stephen R. Baird
Stephen R. Baird GREENBERG TRAURIG, LLP90 SOUTH SEVENTH STREET, SUITE 3500MINNEAPOLIS, MN 55402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Downloadable computer software for controlling and managing patient medical information; Downloadable computer software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Downloadable computer software for acquiring, analyzing, transmitting and storing medical and physiological data; Downloadable computer software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Downloadable computer software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Downloadable computer software for use in the treatment and management of diabetes; Downloadable computer software for linking medical instruments and devices for use in the treatment and management of diabetes; Downloadable computer software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Downloadable computer software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Downloadable computer software for monitoring blood glucose in connection with blood glucose monitors; Downloadable computer software for controlling insulin delivery in connection with insulin pumps; Downloadable computer software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Downloadable computer software for obtaining, controlling, and managing patient medical information on wearable medical devices; Downloadable computer software for controlling and managing wearable insulin delivery devices; Downloadable computer software used to display, manage, and monitor diabetes management information; Downloadable software in the nature of a mobile application for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Downloadable software in the nature of a mobile application for controlling and managing patient medical information; Downloadable software in the nature of a mobile application for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Downloadable software in the nature of a mobile application for acquiring, analyzing, transmitting and storing medical and physiological data; Downloadable software in the nature of a mobile application for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Downloadable software in the nature of a mobile application for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Downloadable software in the nature of a mobile application for use in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for linking medical instruments and devices for use in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for monitoring blood glucose in connection with blood glucose monitors; Downloadable software in the nature of a mobile application for controlling insulin delivery in connection with insulin pumps; Downloadable software in the nature of a mobile application for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Downloadable software in the nature of a mobile application for obtaining, controlling, and managing patient medical information on wearable medical devices; Downloadable software in the nature of a mobile application for controlling and managing wearable insulin delivery devices; Downloadable software in the nature of a mobile application used to display, manage, and monitor diabetes management information; Downloadable application programming interface (API) software; Wireless remote controllers for controlling and managing wearable insulin delivery devices | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable cloud-based software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Providing temporary use of non-downloadable cloud-based software for controlling and managing patient medical information; Providing temporary use of non-downloadable cloud-based software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Providing temporary use of non-downloadable cloud-based software for acquiring, analyzing, transmitting and storing medical and physiological data; Providing temporary use of non-downloadable cloud-based software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Providing temporary use of non-downloadable cloud-based software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Providing temporary use of non-downloadable cloud-based software for use in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for linking medical instruments and devices for use in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for monitoring blood glucose in connection with blood glucose monitors; Providing temporary use of non-downloadable cloud-based software for controlling insulin delivery in connection with insulin pumps; Providing temporary use of non-downloadable cloud-based software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Providing temporary use of non-downloadable cloud-based software for obtaining, controlling, and managing patient medical information on wearable medical devices; Providing temporary use of non-downloadable cloud-based software for controlling and managing wearable insulin delivery devices; Providing temporary use of non-downloadable cloud-based software used to display, manage, and monitor diabetes management information; Software as a Service (SAAS) services featuring software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Software as a Service (SAAS) services featuring software for controlling and managing patient medical information; Software as a Service (SAAS) services featuring software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Software as a Service (SAAS) services featuring software for acquiring, analyzing, transmitting and storing medical and physiological data; Software as a Service (SAAS) services featuring software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Software as a Service (SAAS) services featuring software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Software as a Service (SAAS) services featuring software for use in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for linking medical instruments and devices for use in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for monitoring blood glucose in connection with blood glucose monitors; Software as a Service (SAAS) services featuring software for controlling insulin delivery in connection with insulin pumps; Software as a Service (SAAS) services featuring software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Software as a Service (SAAS) services featuring software for obtaining, controlling, and managing patient medical information on wearable medical devices; Software as a Service (SAAS) services featuring software for controlling and managing wearable insulin delivery devices; Software as a Service (SAAS) services featuring software used to display, manage, and monitor diabetes management information; Application service provider (ASP) featuring software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Application service provider (ASP) featuring software for controlling and managing patient medical information; Application service provider (ASP) featuring software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Application service provider (ASP) featuring software for acquiring, analyzing, transmitting and storing medical and physiological data; Application service provider (ASP) featuring software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Application service provider (ASP) featuring software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Application service provider (ASP) featuring software for use in the treatment and management of diabetes; Application service provider (ASP) featuring software for linking medical instruments and devices for use in the treatment and management of diabetes; Application service provider (ASP) featuring software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Application service provider (ASP) featuring software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Application service provider (ASP) featuring software for monitoring blood glucose in connection with blood glucose monitors; Application service provider (ASP) featuring software for controlling insulin delivery in connection with insulin pumps; Application service provider (ASP) featuring software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Application service provider (ASP) featuring software for obtaining, controlling, and managing patient medical information on wearable medical devices; Application service provider (ASP) featuring software for controlling and managing wearable insulin delivery devices; Application service provider (ASP) featuring software for used to display, manage, and monitor diabetes management information; Application service provider featuring application programming interface (API) software; Consultation services relating to computer software; Providing on-line non-downloadable software featuring patient information management tools in the field of diabetes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 26, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 20, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 28, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 22, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 22, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 22, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 15, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 15, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 30, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 30, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Mar 13, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 13, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 13, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 12, 2025 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 12, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jun 4, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 16, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| May 16, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Mar 5, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 21, 2023 | NWAP | NEW APPLICATION ENTERED | — |